Placeholder Banner

BIO Stands United with the President's Goal of Ending Cancer

February 2, 2022
Media Contact
JG

The following statement can be attributed to BIO's President and CEO Dr. Michelle McMurry-Heath:

“President Biden has long been a champion of research to end cancer. He reaffirmed that commitment today with the relaunch of the "Cancer Moonshot."

"Though details are still forthcoming, BIO welcomes this initiative and stands united with the President's goal of ending the untold human suffering from cancer.

"In the coming weeks, we look forward to working with the White House as it develops a long-term strategy, especially as it relates to understanding the effects of all healthcare policies on the development of future cancer cures."

Discover More
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the reintroduction of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance …
WASHINGTON, D.C. –  John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement.“The passage of the Mikaela Naylon Give Kids a Chance Act is a bipartisan victory for children and…
Washington, D.C. (February 2, 2026) -- The Biotechnology Innovation Organization (BIO) today named Joe Franklin, JD, PhD, as its new chief legal and policy officer. Franklin brings deep expertise in the biomedical sector across law, policy, AI, and…